Several topical gene therapies using modified herpes simplex virus (HSV) carrying wild‐type genes such as COL7A1 for RDEB or transglutaminase 1 (TGM1) for autosomal recessive congenital ichthyosis have been developed.10, 11. This evidence concerns the gene COL7A1 and recessive dystrophic epidermolysis bullosa.